Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Fertil Steril. 2016 Nov 11;107(1):110–118. doi: 10.1016/j.fertnstert.2016.10.002

TABLE 2.

Live birth rates by cycle- and transfer-level characteristics among autologous and donor, cryopreserved and fresh oocyte cycles started in 2013.

Characteristic Autologous cycles Donor cycles
Cryopreserved oocytea cycles Fresh oocyte cycles Cryopreserved oocytea cycles Fresh oocyte cycles
Live birth, n (%) P value Live birth, n (%) P value Live birth, n (%) P value Live birth, n (%) P value
All cycles 100 (23.7) 27,266 (29.3) 955 (43.0) 4,789 (49.4)
 Patient age at cycle start (y) .11 <.001 .11 .005
  <30 13 (27.7) 4,621 (42.5) 8 (29.6) 135 (47.9)
  30–34 27 (25.7) 11,314 (38.9) 65 (41.9) 465 (55.0)
  35–39 32 (28.8) 9,069 (28.3) 196 (47.1) 1,004 (50.9)
  ≥40 28 (17.6) 2,262 (10.7) 686 (42.2) 3,184 (48.3)
 No. of prior pregnanciesb .48 <.001 .61 .87
  0 52 (25.2) 13,320 (30.8) 394 (43.9) 1,897 (49.3)
  ≥1 48 (22.3) 13,919 (27.9) 557 (42.4) 2,871 (49.5)
 No. of prior birthsb .13 .01 .45 .27
  0 84 (25.1) 19,889 (29.6) 684 (42.5) 3,460 (49.0)
  ≥1 16 (18.4) 7,336 (28.5) 265 (44.3) 1,306 (50.5)
 No. of prior ART cyclesb .33 <.001 .03 .99
  0 18 (29.0) 17,709 (33.0) 467 (45.5) 2,023 (49.4)
  ≥1 82 (22.8) 9,509 (24.2) 488 (40.8) 2,761 (49.4)
 Reason for ART
  Diminished ovarian reserve 19 (18.1) .16 4,762 (17.4) <.001 774 (43.0) .89 3,627 (49.2) .66
  No diminished ovarian reserve 81 (25.6) 22,504 (34.2) 181 (42.7) 1,162 (50.1)
  Endometriosis 7 (22.6) .88 2,775 (31.4) <.001 46 (42.2) .88 255 (48.9) .84
  No endometriosis 93 (23.8) 24,491 (29.0) 909 (43.0) 4,534 (49.4)
  Ovulation disorder 16 (30.2) .20 4,610 (37.4) <.001 32 (53.3) .05 158 (57.0) .01
  No ovulation disorder 84 (22.8) 22,656 (28.0) 923 (42.7) 4,631 (49.2)
  Tubal factor d .05 3,793 (28.3) .04 59 (39.6) .37 286 (42.2) .01
  No tubal factor 96 (24.9) 23,473 (29.4) 896 (43.2) 4,503 (50.0)
  Uterine factor SUPP .06 1,046 (23.1) <.001 55 (45.8) .63 279 (46.1) .15
  No uterine factor 98 (24.4) 26,220 (29.6) 900 (42.8) 4,510 (49.6)
  Male factor 49 (29.7) .07 10,850 (33.4) <.001 143 (44.7) .52 802 (50.8) .33
  No male factor 51 (19.8) 16,416 (27.1) 812 (42.7) 3,987 (49.1)
  Other 23 (19.2) .20 2,861 (23.9) <.001 149 (44.7) .48 930 (50.4) .57
  No other 77 (25.5) 24,405 (30.0) 806 (42.6) 3,859 (49.2)
  Unexplained d .26 4,621 (33.6) <.001 52 (39.1) .44 194 (45.5) .47
  No unexplained 96 (24.2) 22,645 (28.5) 903 (43.2) 4,595 (49.6)
 Clinic size .86 .13 .20 .34
  0–99 cycles d 1,129 (26.7) SUPP 138 (42.2)
  100–199 cycles d 2,946 (30.5) 21 (33.9) 431 (48.9)
  200–499 cycles 14 (26.9) 6,357 (31.0) 80 (38.1) 1,055 (49.5)
  ≥500 cycles 80 (22.9) 16,834 (28.5) 852 (43.9) 3,165 (49.9)
Transfers onlyc 100 (30.6) 27,265 (37.4) 955 (47.0) 4,788 (55.9)
 Age of woman providing oocyte at time of retrieval (y)b .33 <.001 .93 .02
  <30 13 (30.2) 4,549 (50.1) 687 (48.6) 3,654 (56.3)
  30–34 30 (34.9) 11,320 (46.4) 91 (47.2) 625 (56.4)
  ≥35 30 (25.2) 11,396 (28.8) d (50.0) 68 (43.0)
 No. of oocytes retrievedc .18 <.001 <.001
  0–10 14 (23.3) 10,257 (29.7) e 487 (47.7)
  ≥11 48 (32.7) 17,008 (44.3) e 4,301 (57.0)
 Intracytoplasmic sperm injection .92 .46 .38 .08
  Yes 98 (30.5) 20,745 (37.2) 951 (47.0) 3,768 (55.1)
  No d 6,515 (37.8) d 1,018 (59.0)
 No. of embryos cryopreservedb .001 <.001 <.001 <.001
  0 61 (24.6) 10,878 (27.4) 384 (38.9) 786 (44.6)
  ≥1 39 (50.6) 16,295 (49.5) 571 (54.6) 3,965 (58.8)
 Assisted hatching .30 <.001 .13 .07
  Yes 58 (28.4) 8,306 (29.2) 683 (45.5) 798 (50.3)
  No 42 (34.1) 18,959 (42.6) 272 (51.0) 3,990 (57.2)
 No. of embryos transferredb .07 <.001 .98 .001
  1 24 (24.2) 5,897 (34.3) 375 (46.9) 1,324 (51.9)
  ≥2 76 (33.3) 21,368 (38.3) 580 (47.0) 3,464 (57.6)
 Embryo stageb <.001 <.001
  Cleavage (2–3 d) f 8,726 (27.1) e 583 (43.2)
  Blastocyst (5–6 d) f 18,132 (46.0) e 4,112 (58.5)
  Other f 374 (28.6) e 83 (52.5)
a

Cycles started in 2013 where cryopreserved oocytes are thawed with the intent of fertilizing the oocytes and transferring the resulting embryos to the patient.

b

Missing <1% for prior pregnancies, prior births, prior ART cycles, ICSI; missing 1% for cryopreservation; missing 3% for embryo stage among fresh transfers; missing 9% for retrieval age among fresh donor retrievals; missing ≥20% for retrieval age, number of oocytes retrieved, and length of freeze among frozen autologous retrievals and retrieval age among frozen donor retrievals.

c

Percentages are among cycles transferring at least one embryo.

d

Suppressed for confidentiality. Either count was between 1 and 5 or cell contents allowed for the calculation of a count between 1 and 5.

e

Donor cycles could not be linked to a retrieval.

f

Autologous cycles could be linked to a retrieval, but embryo stage was only available for retrievals resulting in transfer (i.e. not banking cycles).

Crawford. Cryopreserved oocyte cycles. Fertil Steril 2016.